| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 05/19/2004 | CN1496739A Application of probuco monoester in treating angiocardiopathy and inflammatory disease |
| 05/19/2004 | CN1150181C Substituted benzopyran analogs for treatment of inflammation |
| 05/19/2004 | CN1150178C Sidechain-bearing taxanes |
| 05/19/2004 | CN1150152C Acetals, their preparation and use |
| 05/18/2004 | US6737440 2,5-bis ((alkyl (or aryl) imino) aminophenyl) furans, thiophenes or pyrroles |
| 05/18/2004 | US6737426 Such as (4-phenylsulfonyl-2-pyridin-3-yl-oxazol-5-yl)-methylamine; anticonvulsants, antiinflammatories, neuro-protectants, cerebroprotectants, nootropics |
| 05/18/2004 | US6737423 Substituted heterocyclo-norbornylamino derivatives, processes for their preparation, their use as medicaments or diagnostics, and medicaments comprising them |
| 05/18/2004 | US6737420 Compounds to treat Alzheimer's disease |
| 05/13/2004 | WO2004039792A1 Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture |
| 05/13/2004 | WO2004039768A1 Bifunctional phenyliso(thio)cyanates; method and intermediate products for the production thereof |
| 05/13/2004 | WO2004039764A1 Novel amide compounds with mch antagonistic effect and medicaments comprising said compounds |
| 05/13/2004 | WO2004026305A9 Diaryl ethers as opioid receptor antagonist |
| 05/13/2004 | WO2004022529A3 Diarylurea derivatives and their use as chloride channel blockers |
| 05/13/2004 | WO2003106461A3 Pseudopolymorphic forms of a hiv protease inhibitor |
| 05/13/2004 | US20040092770 Alpha-haloenamine reagents |
| 05/13/2004 | US20040092755 Cyanation of 1-(3-(Dimethylamino)propyl)-1-(phenyl)-1,3-dihydro-5-halo--isobenzofuran with cuprous cyanide to form citalopram |
| 05/13/2004 | US20040092753 Method for producing unsaturated cyclic ethers |
| 05/13/2004 | US20040092598 Antiproliferative agnets; anticancer agents; skin disorders |
| 05/13/2004 | US20040092576 2-oxo-1-pyrrolidine derivatives, process for preparing them and their uses |
| 05/13/2004 | US20040092556 Aids therapy |
| 05/13/2004 | US20040092552 Antiinflammatory agents; cyclooxygenase inhibitors |
| 05/13/2004 | US20040091951 Assay for measuring acetylation or deacetylation activity of an enzyme |
| 05/12/2004 | EP1418176A1 Pyrazole derivates, their preparation and their use in drugs |
| 05/12/2004 | EP1418173A1 N-(3-butyn-1-yl) N-hydroxyurea |
| 05/12/2004 | EP1417194A1 Method for producing maleic anhydride |
| 05/12/2004 | EP1416949A1 Method for isolating terpene trilactones (ginkgolides, bilobalide) from leaves and pharmaceutical powders of ginkgo biloba |
| 05/12/2004 | EP1416928A2 N-monoacylated derivatives of o-phenylenediamines, their six membered heterocyclic analogues and their use as pharmaceutical agents |
| 05/12/2004 | EP1416927A1 Sesquiterpenoid derivatives having adipocyte differentiation inhibitory effect |
| 05/12/2004 | EP1163208B1 Caspase inhibitors and uses thereof |
| 05/12/2004 | EP1097128B1 Imidamide derivatives |
| 05/12/2004 | EP1015429B1 Benzimidazolinones, benzoxazolinones, benzopiperazinones, indanones, and derivatives thereof as inhibitors of factor xa |
| 05/12/2004 | EP0923371B1 Pharmaceutical compositions comprising tyrphostins |
| 05/12/2004 | EP0917464B1 Use of amines to produce drugs for preventing tumour cell proliferation |
| 05/12/2004 | EP0912537B1 Process of preparing phenyl heterocycles useful as cox-2 inhibitors |
| 05/12/2004 | EP0891346B1 Dihydrobenzofuran compounds useful as anti-inflammatory agents |
| 05/12/2004 | CN1496358A Process for preparation of citalopram |
| 05/12/2004 | CN1496281A Improved method for producing unsaturated cyclic ethers |
| 05/12/2004 | CN1495542A Electric photographic photoreceptor, imaging processing cartidge and electric photographic device |
| 05/12/2004 | CN1495164A Method for preparing chiral lactone |
| 05/12/2004 | CN1495157A Preparation method of cyanophthaofluoroaniline |
| 05/12/2004 | CN1495150A Aldehyde acetal preparation method |
| 05/12/2004 | CN1149208C Method for prepn. of 5-cyano 2-benzo[c]furanone |
| 05/12/2004 | CN1149207C Method for preparing gama-unsaturated beta-lactone and use thereof as aromatic and flavouring ingredient |
| 05/11/2004 | US6734318 Fluorous triphase and ther multiphase systems for effecting reactions and/or separation |
| 05/11/2004 | US6734207 For inhibiting the proliferation of tumor cells; as anticancer agent |
| 05/11/2004 | US6734203 Fused imidazolium derivatives |
| 05/11/2004 | US6734186 Phosphodiesterase 2 inhibitor |
| 05/11/2004 | US6734135 Vanadium/phosphorus mixed oxide catalyst precursor |
| 05/11/2004 | US6733690 Acrylic ester polymers |
| 05/06/2004 | WO2004037879A2 Monomers containing at least one biaryl unit and polymers and derivatives prepared therefrom |
| 05/06/2004 | WO2004037808A1 2 - substituted heterocyclic compounds and antitumor composition comprising the same |
| 05/06/2004 | WO2004037805A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/06/2004 | WO2004037804A1 Furan derivatives for preventing and curing osteoporosis and pharmaceutical compositions containing the same |
| 05/06/2004 | WO2004037800A1 Aryloxyalkylamine derivates as h3 receptor ligands |
| 05/06/2004 | WO2004037776A2 Novel compounds and their use as prar-modulators |
| 05/06/2004 | WO2004037775A1 Novel compounds useful in treating ppar mediated diseases |
| 05/06/2004 | WO2004037169A2 Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 05/06/2004 | WO2004011423A3 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 05/06/2004 | WO2004002953A3 Lactone compounds, for use as antioxidant agents in pharmaceutical, cosmetic or food compositions |
| 05/06/2004 | WO2003040096A3 N, n'-substituted-1,3-diamino-2-hydroxypropane derivatives |
| 05/06/2004 | US20040087797 Dihydro-furan-2-one derivatives, their intermediates and methods of manufacture |
| 05/06/2004 | US20040087650 Inhibitors of IMPDH enzyme |
| 05/06/2004 | US20040087646 2-Oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 05/06/2004 | US20040087640 Administering by mouth; cyclooxygenase inhibitor; controlling particle size |
| 05/06/2004 | US20040087627 Decarboxylase inhibitors; cardiovascular diosrders; antidiabetic agents; anticancer agents; dietetics |
| 05/06/2004 | US20040087625 Dietetics; antilipemic agents; anticholesterol agents; reducing triglycerides |
| 05/06/2004 | US20040087620 Terphenyl compounds bearing substituted amino groups |
| 05/06/2004 | US20040087590 Novel biphenyl and biphenyl-like cannabinoids |
| 05/06/2004 | US20040087585 Peptide deformylase inhibitors |
| 05/06/2004 | US20040087583 Kinase inhibitors; antiinflammatory agents; autoimmune diseases; anticancer agents |
| 05/06/2004 | US20040087491 Electrophilic ketones for the treatment of herpesvirus infections |
| 05/06/2004 | EP1415987A1 Nitrogenous aromatic ring compounds |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1414815A1 Tetrahydropyridazine derivatives and their use as pesticides |
| 05/06/2004 | EP1414788A1 Naphthylurea and naphthylacetamide derivatives as vanilloid receptor 1 (vr1) antagonists |
| 05/06/2004 | EP1414778A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 05/06/2004 | EP1414442A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 05/06/2004 | EP1414435A1 Crystalline composition containing escitalopram |
| 05/06/2004 | EP1343777B1 Methanesulphonamido-benzofuran, preparation method and use thereof as synthesis intermediate |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1134216B1 Anti-drug resistant strain agents and antichlamydia agents |
| 05/06/2004 | EP0968182B1 Hydroxamic and carboxylic acid derivatives having mmp and tnf inhibitory activity |
| 05/06/2004 | CA2503280A1 Allyloxy and allylsulfanyl compounds and use thereof as ppar modulators |
| 05/06/2004 | CA2503276A1 Novel compounds useful in treating ppar mediated diseases |
| 05/06/2004 | CA2503015A1 Novel tricyclic compounds useful for the treatment of inflammatory and allergic disorders: process for their preparation and pharmaceutical compositions containing them |
| 05/05/2004 | CN1494545A 非核苷逆转录酶抑制剂 Non-nucleoside reverse transcriptase inhibitors |
| 05/05/2004 | CN1494532A New asymmetric process for preparation of diarylmethylpiperazines derivatives and novel asymmetric diarylmetylamines as intermediates |
| 05/05/2004 | CN1493569A Method of preparing gamma-butyrolactone and/or 1,4-butanediol using chromium less catalyst |
| 05/05/2004 | CN1148346C Hydrazine derivs. |
| 05/04/2004 | US6730810 Anhydride stabilization |
| 05/04/2004 | US6730808 Oxidative reactions using membranes that selectively conduct oxygen |
| 05/04/2004 | US6730800 Catalytic hydrogenation in gas phase of dicarboxylic acids in presence of copper monoxide; etherification, cyclization |
| 05/04/2004 | US6730799 O-hydroxyethyl-o'-methyl-benzofurandione dioximes are rearranged in the presence of a diluent and in the presence of an acid or a base |
| 05/04/2004 | US6730798 Simultaneous halogenation and hydroxylation under lactonization, azidation, then amination to form 2(s),4(s),5(s),7(s)-2,7-dialkyl-4-hydroxy-5-amino-8-aryl-octanoyl amides |
| 05/04/2004 | US6730792 β3 adrenergic agonists |
| 05/04/2004 | US6730783 Reacting aminoguanidine with carbonyl compound to form amidinohydrazone; reduction; reacting with alkoxyamine; guanidinylation; anticoagulants |
| 05/04/2004 | US6730705 Alkoximino acetic acid amides |
| 05/04/2004 | US6730669 Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors |
| 05/04/2004 | US6730631 Producing phthalic anhydride; surfactant system |
| 04/29/2004 | WO2004035570A1 Large conductance calcium-activated k channel opener |